Multiple Sclerosis (MS) is a chronic immune-modulated disorder of the central nervous system (CNS) affecting mainly young adults. Due to the complexity and heterogenic etiology of this disease diagnosis, treatment, and estimations concerning the future course of the disease for the individual patient are challenging. To encounter the variability in phenotype, disease progression and response to treatments, various new drugs are in development to complement existing treatment options. Since years intensive efforts are directed to identify biomarkers that are associated with various aspects of MS on different levels of the organizational hierarchy of the human body (e.g. DNA, RNA, proteins, cells) McLaughlin PJ, Zagon IS A New Biotherapeutic Approach for the Treatment of Multiple Sclerosis.
The Journal of Multiple Sclerosis (JMSO) is scholarly open access journal found on two key tenets: To publish exciting findings based on Multiple Sclerosis and to provide to maintain an article gallery or a research library for researchers, academic persons and medical students. All the published articles will be available in the pdf, html, and abstract formats. The journal also has a supporting conference on Neurology and therapeutics. The main objectives of the journal includes maintenance of publication ethics and thus to meet the scientific excellence.
Last date updated on January, 2021